We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Final statement from the Joint Committee on Vaccines and Immunisation (JCVI) on the groups that should be prioritised for vaccination in phase 2 of the programme.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the benefits of a third primary COVID-19 vaccine dose in individuals aged 12 years and over with severe immunosuppression.
Statement setting out advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the COVID-19 vaccination programme for spring 2024 and beyond.
Statement updating the advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the COVID-19 vaccination programme for autumn 2023.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) about increasing the short-term impact of the COVID-19 vaccination programme.
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) on a COVID-19 booster vaccine programme for winter 2021 to 2022.
Statement setting out the advice from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccination for children aged 6 months to 4 years.
Statement setting out the interim advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the COVID-19 vaccination programme for 2023.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccination of children and young people aged 5 to 11 years and booster vaccinations in those aged 12 to 17 years.
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) in response to the emergence of the Omicron variant.
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the coronavirus (COVID-19) autumn booster programme for 2022.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on the use of the AstraZeneca COVID-19 vaccine.
Advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the groups that should be prioritised for vaccination.
Statement setting out the latest advice from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccines for autumn 2022.
Statement setting out the advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the spring 2023 COVID-19 vaccination programme.
Interim advice from the JCVI on the requirements for a potential COVID-19 booster vaccination programme for winter 2021 to 2022
Updated statement from the Joint Committee on Vaccination and Immunisation (JCVI) on COVID-19 vaccination of children and young people aged 12 to 17 years
Updated advice from the Joint Committee on Vaccination and Immunisation (JCVI) on the COVID-19 booster vaccine programme for winter 2021 to 2022.
Statement from the Joint Committee on Vaccination and Immunisation on vaccinating children aged 5 to 11.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.